A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Clinical trial NCT01128218 · COMPLETED
Trial details
- NCT number
- NCT01128218
- Sponsor
- Southern Illinois University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2021-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.